Sponsor:
National Institutes of Health
Updated Date:
Feb 2, 2024
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2024
(NOT-OD-24-057)
National Institutes of Health
General Notices
- Notice of Information: Research Opportunity Announcement for DS-Connect: The Down Syndrome Registry Targeted Solicitation
(NOT-HD-24-002)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Pre-Application Webinar for RFA-NR-24-004: Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
(NOT-NR-24-006)
National Institute of Nursing Research
National Center for Complementary and Integrative Health
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Research on Women's Health
- NINDS Requirements for Induced Pluripotent Stem Cell Development and Resource Sharing
(NOT-NS-24-019)
National Institute of Neurological Disorders and Stroke
- Request for Information on Potential Solutions for Reducing Publication Bias Against Null Studies
(NOT-NS-24-052)
National Institute of Neurological Disorders and Stroke
Notice of Changes to Funding Opportunities
- Notice of Change in Eligible Organizations for PAR-24-038 Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed)
(NOT-DE-24-013)
National Institute of Dental and Craniofacial Research
- Notice of Changes to RFA-EB-21-001, "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)"
(NOT-EB-24-002)
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
- Notice of Change: Extension of RFA-NS-24-028 - BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
(NOT-NS-24-025)
National Institute of Neurological Disorders and Stroke
- Notice of Change: Extension of PA-21-219: Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
(NOT-NS-24-054)
National Institute of Neurological Disorders and Stroke
- Notice to Rescind NOT-NS-14-032 "NINDS Requirements for Induced Pluripotent Stem Cell Development and Resource Sharing"
(NOT-NS-24-058)
National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Deriving Common Data Elements from Real-World Data for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U24 Clinical Trial Not Allowed)
(NOT-AG-23-080)
National Institute on Aging
- Notice of Intent to Publish HEAL KIDS (Knowledge, Innovation and Discovery Studies): Chronic Pain Program (UC2 Clinical Trial Optional)
(NOT-AR-24-006)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Behavioral and Social Sciences Research
Requests for Proposal
- Request for Proposals (RFP) Notice: Medication Discovery Using Rat Models of Relapse
(NOT-DA-23-063)
National Institute on Drug Abuse
Notices of Special Interest
- Notice of Special Interest (NOSI): RNA Delivery Technologies to Allow Specific Tissue Target Homing (RNA-DASH)
(NOT-AI-24-007)
National Institute of Allergy and Infectious Diseases
National Center for Advancing Translational Sciences
National Cancer Institute
- Notice of Special Interest (NOSI): Strategies to Address Stigmatizing Beliefs and Policies Affecting People Who Use Drugs
(NOT-DA-25-029)
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Impact of Policy Interventions Aimed at Addressing Social Determinants of Health to Improve Functioning and Well-being for People with Serious Mental Illnesses
(NOT-MH-24-340)
National Institute of Mental Health
Funding Opportunities
- NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
(PAR-24-099)
National Institute of Allergy and Infectious Diseases - NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
(PAR-24-100)
National Institute of Allergy and Infectious Diseases - NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
(PAR-24-115)
National Center for Complementary and Integrative Health - NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
(PAR-24-116)
National Center for Complementary and Integrative Health - Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
(PAR-24-123)
National Center for Complementary and Integrative Health - NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
(PAR-24-124)
National Center for Complementary and Integrative Health - Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trial Optional)
(RFA-DA-25-032)
National Institute on Drug Abuse - Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Basic Experimental Studies with Humans (BESH) Required)
(RFA-DA-25-033)
National Institute on Drug Abuse - Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not Allowed)
(RFA-DA-25-034)
National Institute on Drug Abuse - Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R41/R42 Clinical Trials Not Allowed)
(RFA-DA-25-053)
National Institute on Drug Abuse - Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R43/R44 Clinical Trials Not Allowed)
(RFA-DA-25-054)
National Institute on Drug Abuse - Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required)
(RFA-DK-23-011)
National Institute of Diabetes and Digestive and Kidney Diseases - Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) by State, Local, Tribal, and Territorial (SLTT) Retail Food Regulatory Agencies (U19) Clinical Trials Not Allowed
(RFA-FD-24-033)
Food and Drug Administration - Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional
(RFA-FD-24-038)
Food and Drug Administration - Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U19) Clinical Trials Not Allowed
(RFA-FD-24-039)
Food and Drug Administration - NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed)
(RFA-NS-24-030)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 313-335-2123, or email Ann Ricketts or Lynn Hudachek.
